FY’20 Year End and Q4 Financial Results
December 17th, 2020
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
APDN Awarded Pooled Surveillance Testing Contract Valued at Up to $2M
December 17th, 2020
NY Winter COVID-19 Plan Drives Demand for Applied DNA’s Pooled Surveillance Testing Program
December 11th, 2020
Applied DNA Schedules Fiscal 2020 Fourth Quarter Financial Results Conference Call for Thursday, December 17, 2020 at 4:30 PM EST
December 8th, 2020
Nutrition21 Transitions to CertainT® Platform to Secure Portfolio of Dietary Supplement Ingredients
December 7th, 2020
Applied DNA to Provide COVID-19 Surveillance Testing to Stony Brook Basketball
December 1st, 2020
APDN, Evvivax and GVS Receive Approval for Veterinary COVID-19 Clinical Trial
November 30th, 2020
APDN to Present at Imperial Capital 2020
November 27th, 2020
Applied DNA Significantly Expands Addressable Market for Linea™ COVID-19 Assay Kit via Successful Amendment to FDA EUA
November 25th, 2020
